← back to search

Emily Mitchell

Wellcome/MRC Cambridge Stem Cell Institute · GB
Area of research
Cancer Research · Hematology
Research interest
Research interests include Cancer Genomics and Diagnostics, Acute Myeloid Leukemia Research, Single-cell and spatial transcriptomics, and Hematopoietic Stem Cell Transplantation.
h-index
21
citations
2,845
works
64
NIH funding
primary concept
Biology
email

Recent publications

Clonal dynamics and somatic evolution of haematopoiesis in mouse
Nature 2025cited by 29position: middledoi
Prolonged persistence of mutagenic DNA lesions in somatic cells
Nature 2025cited by 28position: middledoi
TopoQual polishes circular consensus sequencing data and accurately predicts quality scores
BMC Bioinformatics 2025cited by 3position: middledoi
Author Correction: Clonal dynamics and somatic evolution of haematopoiesis in mouse
Nature 2025cited by 0position: middledoi
TopoQual polishes circular consensus sequencing data and accurately predicts quality scores
bioRxiv (Cold Spring Harbor Laboratory) 2024cited by 13position: middledoi
Clonal dynamics and somatic evolution of haematopoiesis in mouse
bioRxiv (Cold Spring Harbor Laboratory) 2024cited by 6position: middledoi
Mutagenic DNA Lesions in Normal Hematopoietic Stem Cells Persist for Years Causing Distinct Patterns of Mutation
Blood 2024cited by 1position: middledoi
Genotoxic aldehyde stress prematurely ages hematopoietic stem cells in a p53-driven manner
Molecular Cell 2023cited by 40position: middledoi
Convergent somatic evolution commences in utero in a germline ribosomopathy
Nature Communications 2023cited by 21position: middledoi
Prolonged persistence of mutagenic DNA lesions in stem cells
Research Square 2023cited by 5position: middledoi
The longitudinal dynamics and natural history of clonal haematopoiesis
Nature 2022cited by 353position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 4 papers (2022–2024)Jyoti Nangalia · Wellcome Sanger Institute4 papers (2022–2024)Peter J. Campbell · Quotient Clinical (United Kingdom)4 papers (2022–2024)George S. Vassiliou · Wellcome/MRC Cambridge Stem Cell Institute3 papers (2022–2023)E. Joanna Baxter · Bridge University2 papers (2022–2023)Margarete A. Fabre · AstraZeneca (United Kingdom)2 papers (2022–2023)Haynes Heaton · Auburn University2 papers (2024–2025)Minindu Weerakoon · Auburn University2 papers (2024–2025)Elisa Laurenti · Wellcome/MRC Cambridge Stem Cell Institute2 papers (2023–2023) · 2 papers (2024–2025)Michael Spencer Chapman · Wellcome Sanger Institute2 papers (2022–2023)Iñigo Martincorena · Wellcome Sanger Institute2 papers (2022–2023) · 1 papers (2023–2023) · 1 papers (2023–2023) · 1 papers (2023–2023)Laura T. L. Brandt · McMaster University1 papers (2023–2023)Aristi Damaskou · Cambridge University Hospitals NHS Foundation Trust1 papers (2022–2022)Laura J. Niedernhofer · University of Minnesota1 papers (2024–2024)Justyna Rak · Wellcome/MRC Cambridge Stem Cell Institute1 papers (2022–2022)Michele Marongiu · University of Michigan–Ann Arbor1 papers (2022–2022)